BONEX (BONEX) News
Follow BONEX (BONEX) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 8 public stories across 6 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
L
BONESUPPORT Holding AB (BONEX) Buys Back 60,000 Shares in Week 39
BONESUPPORT repurchased 60,000 ordinary shares on Sept 21—25, 2026 under its buyback program of up to SEK 100M running through Oct 30, 2026. Treasury holdings now total 605,320 ordinary shares and 905,155 Series C shares
EQUITY | Sep 28, 2026, 12:57 PM UTC
M
BONESUPPORT submits complete CERAMENT V De Novo additional data to FDA
BONESUPPORT Holding AB said it has submitted the complete additional data package for the CERAMENT V De Novo submission to the U.S. FDA.
REGULATION | Sep 21, 2026, 06:01 AM UTC
M
NEJM publishes SOLARIO study supporting short systemic antibiotics with CERAMENT
BONESUPPORT AB said NEJM published SOLARIO showing ≤7 days systemic antibiotics were noninferior to ≥4 weeks when combined with local antibiotics; CERAMENT G/V were used in most cases.
EQUITY | Sep 17, 2026, 07:41 AM UTC
L
BONESUPPORT repurchases 44,000 shares in buy-back Sept 1-4, 2026
BONESUPPORT HOLDING AB repurchased 44,000 own ordinary shares during Sept. 1, 2026 up to and including Sept. 4, 2026 as part of its buy-back program initiated Sept. 1, 2026.
EQUITY | Sep 07, 2026, 01:25 PM UTC
L
BONESUPPORT launches share buyback program up to SEK 100 million
BONESUPPORT’s board resolved to initiate a share buy-back program of up to SEK 100 million, authorized by the 2026 annual general meeting, to adapt the company’s capital structure.
EQUITY | Sep 01, 2026, 11:15 AM UTC
L
BONESUPPORT: Another turn in the CERAMENT V FDA process
BONESUPPORT: Another turn in the CERAMENT V FDA process
REGULATION | Aug 27, 2026, 10:07 AM UTC
L
Bonesupport Holding: FDA extends Cerament V submission deadline
Bonesupport Holding says the FDA extended the submission deadline for its Cerament V data package.
REGULATION | Aug 27, 2026, 06:14 AM UTC
L
CERAMENT® V DE NOVO SUBMISSION UPDATE
CERAMENT® V DE NOVO SUBMISSION UPDATE
EQUITY | Aug 27, 2026, 06:01 AM UTC